Navigation Links
HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
Date:8/10/2012

FRAMINGHAM, Mass. and SYDNEY, Aug. 10, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 32nd Annual Growth Conference at 8:00 a.m. EDT on Wednesday, August 15, 2012.  The conference is being held August 14-16, 2012 at the InterContinental Hotel in Boston.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare has received CE Marking for the HeartWare System in the European Union and TGA approval in Australia.  The device is currently the subject of United States clinical trials for two indications: bridge-to-transplant and destination therapy.  For additional information, please visit www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

<
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
2. HeartWare Reports Second Quarter 2012 Results
3. HeartWare Completes Acquisition Of World Heart Corporation
4. HeartWare Schedules Second Quarter Conference Call And Webcast
5. HeartWare Names Peter F. McAree Chief Financial Officer
6. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
7. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
8. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
9. Heartware Schedules First Quarter Conference Call And Webcast
10. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
11. Cepheid to Webcast Upcoming Financial Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... 2014   InnFocus, Inc ., reported on results of ... for up to 3 years with the InnFocus ... Chicago . The Summit ... meeting of the American Academy of Ophthalmology . The ... glaucoma patients in 6 countries by early 2015. ...
(Date:10/17/2014)... 2014  China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... received approval from the China Food and Drug ... prothrombin complex concentrate ("PCC") at its Shandong Taibang ... factor production facility for Good Manufacturing Practices ("GMP") ...
(Date:10/17/2014)... --  DaVita HealthCare Partners Inc. (NYSE: ... and most innovative health care communities, recently held ... award-winning, leadership development and cultural orientation program for ... the globe were in attendance for the event. ... two-day one-of-a-kind experience for new and recently hired ...
Breaking Medicine Technology:InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3
... The American Association for Homecare supports tough anti-fraud ... and Commerce subcommittee hearing on this issue this week ... taxpayer dollars. The American Association for Homecare represents providers ... We have zero tolerance for fraud and ...
... Sept. 22 NewBridge Pharmaceuticals announced that it has ... AB (STO: ORX) that grants NewBridge rights to seek ... cancer pain, in the Middle East and Africa and, ... product in these territories.  The agreement covers 64 countries ...
Cached Medicine Technology:Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 2Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 3Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 4Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 5Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 6Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 7NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 2NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 3NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 4
(Date:10/20/2014)... 2014 hc1.com today announced the ... solution that enables healthcare organizations of all sizes ... customer relationship management (“CRM”) solution. , Designed from ... of the healthcare industry, the hc1 Healthcare Relationship ... patients by combining healthcare CRM, HIPAA-compliant collaboration, and ...
(Date:10/20/2014)... Dunbridge, Ohio (PRWEB) October 20, 2014 ... 50 years, takes pride in manufacturing top-of-the-line absorbent products. ... the image of its most popular brand, Tranquility® Premium ... logo, created a new website, gave its packaging a ... to bring the brand message to the public. , ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The Center ... hospital ROI on membership dues at 12.5. In other words, ... in value to member hospitals. The calculation used to determine ... , “This is the first time we’ve actually been ... methodology is really sound,” said Bill Ryan , president ...
(Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
Breaking Medicine News(10 mins):Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... famous for talking to animals, then here,s a story that ... published online in The FASEB Journal ( http://www.fasebj.org ... subcutaneous adipose (fat) tissue with muscle cells from rat hearts. ... cells altogether, but they actually beat. "Recovery of regenerative ...
... Grafton, Mass., February 28, 2011 Researchers at the Cummings ... an antibody-based treatment for Hemolytic Uremic Syndrome (HUS), a potentially ... leading cause of kidney failure in children. HUS is ... produce Shiga toxins and are responsible for about 100,000 annual ...
... lll. A farmer in Niger learns how to protect ... rural Haitian village learns how to avoid exposure to cholera. ... oil from shea seeds to make shea butter she can ... from a new approach to sustainable development education that reaches ...
... WASHINGTON, February 28, 2011) Results from a study ... American Society of Hematology reveal a close relationship between ... arteries carrying blood from the heart to the lungsand ... (known as myeloid abnormalities). The study, which was ...
... in breast cancer incidence rates among non-Hispanic white women ... use of postmenopausal hormone therapy did not continue through ... Cancer Society and the National Cancer Institute. While there ... may indicate that the decrease in breast cancers thought ...
... (HealthDay News) -- A new study finds that heart attack ... other heart attack patients to receive priority care at emergency ... patients admitted to 96 hospitals in the province of Ontario ... had a history of depression recorded in their medical charts. ...
Cached Medicine News:Health News:Human stem cells from fat tissue fuse with rat heart cells and beat 2Health News:Tufts receives patent for antibody treatment against hemolytic uremic syndrome 2Health News:Team delivers development aid via cell phone animations 2Health News:Team delivers development aid via cell phone animations 3Health News:Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities 2Health News:Study finds breast cancer incidence rates no longer declining in US women 2Health News:Heart Patients With Depression Often Find ER Delays 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: